Demand for improved pharmaceutical care that enhances the patient experience is ever increasing, and meanwhile outcomes-based medicine has become a key focus for health authorities around the world
Having clear parameters of patient‑centricity that can be measured year-on-year enables Boehringer Ingelheim UK to know if it is moving in the right direction and to set targets for what it hop
Chronic obstructive pulmonary disease (COPD) is a progressive and debilitating disorder, which, as it progresses, places a significant burden on individuals and those caring for them.
Today, pharma brand planning teams can benefit from technology platforms that aggregate data and automate analyses, helping unlock insights on the market landscape and clinical environment